Ligand Reports Fourth Quarter and Full Year 2025 Financial Results
Feb 26, 2026 · Ligand management will host a conference call and webcast today beginning at 8:30 a.m. Eastern time to discuss this announcement and answer questions. “We delivered strong fourth …
Ligand Reports First Quarter 2025 Financial Results
May 8, 2025 · First quarter performance driven by strong portfolio royalty revenue growth of 44% Strengthened commercial portfolio and pipeline through strategic transactions with Channel …
Ligand and Medtronic Commit $70 Million in Strategic Capital to ...
Jul 31, 2025 · Ligand to invest $35 million in exchange for a tiered royalty on future sales of Orchestra’s AVIM therapy and Virtue SAB, plus $5 million in an equity private placement Medtronic to invest $10 …
Ligand Pharmaceuticals Incorporated - Investor Relations
Feb 26, 2026 · Ligand is a biopharmaceutical company that invests in the groundbreaking medicines of today and tomorrow. We fund the clinical development and commercialization of high-value …
Ligand Hosts 2025 Investor Day and Introduces 2026 Guidance
Dec 9, 2025 · Introduces 2026 full year revenue guidance of $245 million to $285 million, an approximately 15% increase in core revenue growth over 2025, royalty revenue of $200 to $225 …
Ligand Pharmaceuticals Incorporated - Ligand Announces Pricing of …
JUPITER, Fla., Aug. 11, 2025 (GLOBE NEWSWIRE) - Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) (“Ligand”) announced today the pricing of $400.0 million aggregate principal amount of …
Financials - Quarterly Results - Ligand Pharmaceuticals
Ligand is not responsible for, and has no role in, the development of such products or programs. Ligand owns or has rights to trademarks and copyrights that it uses in connection with the operation of its …
Ligand Announces Completion of Pelthos Therapeutics Merger with …
Jul 2, 2025 · Pelthos plans to launch ZELSUVMI™ for the treatment of Molluscum contagiosum infections in July 2025 Concurrent with the closing of the merger, Ligand has invested $18 million in …
Ligand to Participate in March Investor Conferences
JUPITER, Fla., March 04, 2026 (GLOBE NEWSWIRE) - Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its senior management team will participate in the following upcoming …
Ligand Pharmaceuticals Incorporated - Ligand to Report Fourth …
Feb 12, 2026 · About Ligand Pharmaceuticals Ligand is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of high-value medicines. Ligand …